Abstract

should not be used to modify clinical practice. However, although mortality is objective and important, most patients withCAPdonotdie.BecausenewinterventionsforCAPare likely to result in only small changes in mortality, large sample sizes are required to detect clinically important changes. Therefore, it has been suggested that mortality is an insensitive measure of quality of care or treatment failure in CAP. 3 In our article, 1 we clearly pointed out that our study was not powered to detect a survival difference. Nevertheless, we found that only 4 of 200 patients (2%) in the 3-step group and 2 of 201 patients (1%) in the usual care group died. Importantly, no patient died during the 30-day follow-upperiodafterdischarge.However,itshouldbenoted that patients receiving usual care were more likely to experience adverse drug reactions, mainly phlebitis, probably related to the longer duration of intravenous antibiotic therapy in this group. Webelievethatapplyingthe3-stepcriticalpathway(early mobilizationanduseofobjectivecriteriaforswitchingtooral antibiotics and for deciding on hospital discharge) to the selected population analyzed is safe and effective and may allowcostsavings.Inthisregard,themostrecentInfectiousDiseasesSocietyofAmerica/AmericanThoracicSocietyConsensus

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.